Condition: Liver Resection · Colorectal Carcinoma Liver Metastases · Sponsor: HepaRegeniX GmbH
The goal of this clinical trial is to learn if HRX215 is safe, tolerable and active in adults who have undergone liver resection due to colorectal carcinoma metastases. The objectives are: 1. to learn about the safety and tolerability of HRX215 2. to learn about how the body absorbs, distributes, and gets rid of HRX215. 3. to learn about clinical activity of HRX215 Researchers will compare HRX215 to a placebo (a look-alike substance that contains no drug) to investigate safety, tolerability and clinical activity in participants taking HRX215.
This description comes directly from the study's public registry record.
Wolfgang Albrecht, PhD NC · +49 7071 7912809 · info@heparegenix.com
Linda Greenbaum, MD · 484-343-2409 · l.greenbaum@heparegenix.com
Always discuss trial participation with your own doctor first.
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Not Yet Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Centre Hospitalier Régional Universitaire de Lille (CHRU) Hôpital Claude Huriez | Lille, France | Recruiting |
| Hôpital Paul-Brousse - Centre Hepato-Biliaire (CHB) | Villejuif, France | Recruiting |
| Univ. Tuebingen - Universitaetsklinik fuer Allgemeine, Viszeral- und Transplantationschirurgie | Tübingen, Germany | Recruiting |
| Rabin Medical Center | Petah Tikva, Israel | Recruiting |
| Sheba Medical Center | Ramat Gan, Israel | Recruiting |
| Tel-Aviv Sourasky MC | Tel Aviv, Israel | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Not Yet Recruiting |
| South Texas Accelerated Research Therapeutics Madrid - CIOCC - Universitario Sanchinarro | Madrid, Spain | Recruiting |
| Consorci Hospital General Universitari de València | Valencia, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06638502